• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 6
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue6

Acomparative analysis of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease patients and healthy individuals

    Dr. Dipti mohapatra Dr. Manasi behera Dr.tapaswini mishra

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 6, Pages 824-831

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background/aims: COPD is among the significant health complications in entire world; studies have shown that there is systemic inflammation with pulmonary inflammation in case of COPD. To detect the systemic inflammatory response, neutrophil lymphocyte ratio (NLR) in peripheral blood which is important biomarker. NLR hasn’t been studied in patients having chronic obstructive pulmonary disease (COPD). Current study was targeted to determine the importance of NLR as inflammatory marker in patients with COPD.
Methods: The neutrophil and lymphocyte count in the peripheral blood was found out from blood count (CBC) reports. The NLR was determined by dividing neutrophil count from lymphocyte count. COPD patients were diagnosed with Spirometry. Then the NLR was compared in patients having stable COPD (n = 50), and healthy controls (n = 50.
Results: The neutrophil count was considerably greater in COPD patients matched with the healthy individuals (p < 0.001) whereas the lymphocyte count was suggestively lower in patients having COPD patients when compared to perfectly healthy individuals (p < 0.001).NLR values were considerably higher among patients with stable COPD patients than controls (p < 0.001). There were no noteworthy variance in the total leucocyte of COPD patients and healthy individuals.
Conclusion: It is concluded that the increase in the neutrophil-lymphocyte ratio in COPD patients compared to healthy individuals may be an indicator of systemic inflammation in patients with COPD.
Keywords:
    neutrophil count lymphocyte count neutrophil-lymphocyte ratio COPD
  • PDF (254 K)
  • XML
(2020). Acomparative analysis of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease patients and healthy individuals. European Journal of Molecular & Clinical Medicine, 7(6), 824-831.
Dr. Dipti mohapatra; Dr. Manasi behera; Dr.tapaswini mishra. "Acomparative analysis of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease patients and healthy individuals". European Journal of Molecular & Clinical Medicine, 7, 6, 2020, 824-831.
(2020). 'Acomparative analysis of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease patients and healthy individuals', European Journal of Molecular & Clinical Medicine, 7(6), pp. 824-831.
Acomparative analysis of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease patients and healthy individuals. European Journal of Molecular & Clinical Medicine, 2020; 7(6): 824-831.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 175
  • PDF Download: 243
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus